Skip to content

Clinical Study on the Therapeutic Efficacy of Percutaneous Trigeminal Nerve Electrical Stimulation Combined with Motorized Standing Bed for Patients with Chronic Consciousness Disorders

Clinical Study on the Therapeutic Efficacy of Percutaneous Trigeminal Nerve Electrical Stimulation Combined with Motorized Standing Bed for Patients with Chronic Consciousness Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114184
Enrollment
Unknown
Registered
2025-12-09
Start date
2025-12-15
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Consciousness Disorders

Interventions

Group A: Conventional rehabilitation therapy andTrigeminal nerve electrical stimulation combined with electric standing bed therapy
GroupB:Conventional rehabilitation therapy and trigeminal nerve electrical stimulation therapy
GroupC:Conventional rehabilitation therapy and electric standing bed therapy

Sponsors

The Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: To be eligible for inclusion, all of the following criteria must be met: 1. Age >=18 years; 2. Duration of unconsciousness > 28 days; 3. Diagnosed with persistent vegetative state (PVS) or minimally conscious state (MCS) according to clinical diagnostic criteria and the Coma Rating Scale-Revised (CRS-R); 4. Causes include hypoxia, trauma, and stroke; 5. No prior history of neurological disease.

Exclusion criteria

Exclusion criteria: Exclusion criteria: meet any one of the following: 1. Unstable vital signs; 2. Severe pulmonary infection; 3. Uncontrollable severe infection; 4. Concurrent dysfunction of vital organs (heart, liver, kidneys, etc.) or coagulation disorders; 5. Organ transplant recipients or patients with severe autoimmune diseases; 6. Patients with cachexia due to advanced malignancy or critically low peripheral blood counts; 7. Patients with elevated intracranial pressure; 8. Individuals deemed by the physician to be at high risk of non-compliance with follow-up appointments.

Design outcomes

Primary

MeasureTime frame
Coma Recovery Scale-Revised;Glasgow Coma Scale;Bedside functional near-infrared spectroscopy imaging;

Secondary

MeasureTime frame
electroencephalogram;event-related potential;

Countries

China

Contacts

Public Contactxuchunyan

The Second Affiliated Hospital of Kunming Medical University

68632613@qq.com+86 135 7703 7861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026